Benchmark Maintains Buy on Imax, Lowers Price Target to $25

Benchmark analyst Mike Hickey maintains Imax (NYSE:IMAX) with a Buy and lowers the price target from $28 to $25.

Benchmark analyst Mike Hickey maintains Imax (NYSE:IMAX) with a Buy and lowers the price target from $28 to $25.

Total
0
Shares
Related Posts